Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: A meta-analysis of published double-blind, placebo-controlled clinical trials
- 1 February 2000
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (2) , 209-221
- https://doi.org/10.1016/s0149-2918(00)88479-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Treatment cost of acute exacerbations of chronic bronchitisClinical Therapeutics, 1999
- Meta-analysis of randomized controlled trials. A concern for standards;JAMA, 1995
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysisJAMA, 1995
- Methodologic guidelines for systematic reviews of randomized control trials in health care from the potsdam consultation on meta-analysisJournal of Clinical Epidemiology, 1995
- The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?European Respiratory Journal, 1994
- Clinical Pharmacokinetics of N-AcetylcysteineClinical Pharmacokinetics, 1991
- Oral fabrol (oral N-acetylcysteine) in chronic bronchitisRespiratory Medicine, 1987
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987
- Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee.Thorax, 1985